Health News Archive - May 21, 2010
FRANKLIN, Mass., May 21 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc.
WILMINGTON, Del., May 21 /PRNewswire-USNewswire/ -- AstraZeneca (NYSE: AZN) contributed $1 million to Wilmington Hospital today to support the expansion and renovation of the hospital as a vital part of the Christiana Care Health System.
A new study shows that many heart attack survivors may worry about having a sex life more than they really should, and that doctors play a key role in whether they should or should not.
SILVER SPRING, Md., May 21 /PRNewswire-USNewswire/ -- Do you have questions about indoor tanning? Did you know that the Food and Drug Administration (FDA) regulates tanning beds? (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO) During a 30-minute webinar, experts from FDA will explain what ultraviolet (UV) radiation is and what risks are associated with it.
PHILADELPHIA, May 21 /PRNewswire/ -- Prometheus Research Informatics today was featured in multiple new presentations at the annual International Meeting for Autism (IMFAR), the leading conference on autism research. The presentations at IMFAR detailed results relating to studies on autism symptoms, cognition, clinical phenotypes, genetics, treatment, and social function.
Children with vesicoureteral reflux (VUR), in which urine flows backwards into the kidneys from the bladder, have been treated in the past with surgery or antibiotic therapy.
Special issue of Clinical Infectious Diseases examines new scientific advances to curb HIV, TB epidemics; call for new policy advances to create breakthroughs.
MINNEAPOLIS, May 21 /PRNewswire-FirstCall/ -- Biotel Inc. (OTC Bulletin Board: BTEL) announces results for its third quarter ended March 31, 2010 with a net loss of $126,000, or $0.05 per diluted share, on revenues of $2,409,000.
Researchers from Mount Sinai School of Medicine have identified a drug that improves communication between nerve cells in a mouse model of Phelan-McDermid Syndrome (PMS).
Group program has powerful impact on disease risk, at a fraction of the cost.
- A blustering, bullying fellow; a pot-valiant braggart; a bully.